search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


prospective, observational registration study for women with Inflammatory breast cancer


- candidate number21769
- NTR NumberNTR5152
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR6-mrt-2015
- Secondary IDsMETc 2014/345  
- Public Titleprospective, observational registration study for women with Inflammatory breast cancer
- Scientific TitleINFLAME: Towards optimal treatment of inflammatory breast cancer patients
A study of the Dutch Breast Cancer Research Group (BOOG); BOOG 2014-05
- ACRONYMINFLAME
- hypothesisThe INFLAME project will strengthen national registry collaboration by building upon and expanding previous experience with biobanking experience in rare BC subtypes. INFLAME will be supporting expansion of IBC research within international registry collaborations. Therefore, this project can be a model for the approach of future cancer research in (anticipated) increasingly small subgroups of breast cancer. The relevance of the INFLAME project for patient care clearly lies in the potential improved outcome for IBC patients. Increased IBC awareness due to INFLAME and thereby earlier detection will support this, in addition to improved molecular insights for IBC-specific targeting and detection. Based on the INFLAME project, standardized treatment insights and guidelines may be developed.
- Healt Condition(s) or Problem(s) studiedInflammatory breast cancer
- Inclusion criteriaIn order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Gender: female
- Diagnosis: primary IBC (all stages of the disease)
- Age: ¡Ý18 years old at time of diagnosis
- Mental competence and understanding of the Dutch language are required.
- Exclusion criteriapotential subject being incapacitated or for any reason unable to provide informed consent will be excluded from participation in this study.
- mec approval receivedno
- multicenter trialyes
- randomisedno
- groupParallel
- TypeSingle arm
- Studytypeobservational
- planned startdate 6-feb-2015
- planned closingdate6-feb-2017
- Target number of participants200
- Interventionsnot applicable
- Primary outcomenot applicable
- Secondary outcomenot applicable
- Timepointsnot applicable
- Trial web site
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESMD PhD C.P. Schröder
- CONTACT for SCIENTIFIC QUERIESMD PhD C.P. Schröder
- Sponsor/Initiator BOOG
- Funding
(Source(s) of Monetary or Material Support)
Alpe d’HuZes Foundation
- Publications
- Brief summary
- Main changes (audit trail)
- RECORD6-mrt-2015 - 22-mei-2015


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl